Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration
for
Respiratory Distress Syndrome (Neonatal),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0
Code: NCT07426016
Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Dallas TX, Sherman TX, Kansas City MO, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for
Atrial Fibrillation
Location: Plano TX, Austin TX, Jonesboro AR, Atlanta GA,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07523750
Recruiting
The Return of Cardiovascular Information Trial (RECITE)
for
Health Curiosity, Cardiovascular Health Risk Communication
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 35+
Code: NCT07613853
Recruiting
Cardiopulmonary Stress Testing (CPET) AlloSure Study
for
Heart Failure, Transplant; Failure, Heart
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04656080
Recruiting
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
Location: Plano TX, Houston TX, St Louis MO, Iowa City IA,
Sponsor: Ottawa Heart Institute Research Corporation
Sex: All
Age: 18 - 70+
Code: NCT03536312
Recruiting
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma